Pursuant to section 35(1)(b) of the Medicines Act 1981, the Minister of Health hereby revokes consent to the distribution in New Zealand of the following medicines:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Venlafaxine XR Venlafaxine hydrochloride 84.869mg equivalent to Venlafaxine 75mg Modified release capsule PSM Healthcare Limited trading as API Consumer Brands Wockhardt Limited, Maharashtra State, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Venlafaxine XR Venlafaxine hydrochloride 169.738mg equivalent to Venlafaxine 150mg Modified release capsule PSM Healthcare Limited trading as API Consumer Brands Wockhardt Limited, Maharashtra State, India
|
Dated this 8th day of May 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).